Author Archives: Tigran Dadalyan
Complementary therapies can increase survival in cancer patients
It is well known that a large percentage of cancer patients use some form of complementary and alternative medicine (CAM), usually with the goal of improving quality of life, providing supportive care as well as relieving pain
Metformin is a potential remedy for the treatment of Gaucher disease
Replacement of saturated with unsaturated fats had no impact on vascular function but beneficial effects on lipid biomarkers and blood pressure
Disease of the heart and blood vessels (referred to as cardiovascular disease (CVD)) is the primary cause of death worldwide. A key public health recommendation for reducing the risk of developing CVD is to lower our intake of
Employing more nurse practitioners can lower health care costs
We all want to have access to health care when we are not feeling well and we want to do so without breaking our budget. However there is growing concern about the availability of care and the
Association of polymorphism gene with clinical variability in cystic fibrosis patients
A new drug to prevent vomiting from cancer treatment
Vomiting after drug treatment for cancer used to be a major problem. However 2 different types of drugs were introduced which reduced this vomiting. The first was ondansetron which was very effective for the vomiting which occurred
Plant flavonoids prevent cancer progression through suppression of new blood vessel formation
An innovative method to increase access to surgery worldwide
Ability of four vitamin D assays to measure vitamin D2
Vitamin D, the sunshine hormone, is essential for healthy bones. Vitamin D is found in two basic forms in nature—vitamin D3 which is made by skin exposed to sun rays (cholecaliferol), and vitamin D2 which is made
From the gut to the eye: commensal microbes as potential triggers of autoimmune uveitis
Biodiesel synthesis in response to individual short chain fatty acids during mixotrophic mode of microalgal cultivation
Slug transcription factor activates its own expression during epithelial to mesenchymal transition
Cancer is a highly aggressive and challenging disease. In several instances, symptoms are not evident until the disease progresses to an advanced stage and hence, it is amongst the leading causes of human mortality. Despite considerable attempts
Birth weight is not solely determined by genetic code
Small-molecule RETRA is effective against a fatal childhood cancer
Bone marrow transplantation resets the clock in patients with Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) accounts for about one third of all of leukemias. In the United States 15,000 patients are diagnosed with and 4,500 patients die of CLL every year. CLL is a diverse disease. Some patients
Comparison of biological and cultural evolution
Rare and uncommon cancers
A rare cancer is one that occurs less than 6 times in 100,000 people and an uncommon cancer is found between 6 and 12 times in each 100,000 people. The problem with being rare is that there
Controlling self-assembly processes on 2-D surface
Efficient tuning of carbon surface: Defect-enriched CNT
Agreement between physician’s recommendation and fitness-to-drive decision in multiple sclerosis
Multiple sclerosis (MS) is a progressive disease of the central nervous system with potential debilitating effects on visual, motor and cognitive functions. These functions are essential for daily life activities, such as driving a car. Previous studies






















